Fusogenic Hybrid Extracellular Vesicles with PD-1 Membrane Proteins for the Cytosolic Delivery of Cargos

Abstract

Extracellular vesicles (EVs) are cell-derived lipid membrane capsules that can deliver functional molecules, such as nucleic acids, to target cells. Currently, the application of EVs is limited because of the difficulty of loading cargo into EVs. We constructed hybrid EVs by the fusion of liposomes and insect cell-derived EVs expressing recombinant programmed cell death 1 (PD-1) protein and baculoviral fusogenic glycoprotein gp64, and evaluated delivery of the model cargo molecule, Texas Red-labeled dextran (TR-Dex), into the cytosol. When PD-1 hybrid EVs were added to HeLa cells, the intracellular uptake of the hybrid EVs was increased compared with hybrid EVs without PD-1. After cellular uptake, the PD-1 hybrid EVs were shown to be localized to late endosomes or lysosomes. The results of fluorescence resonance energy transfer (FRET) indicated that membrane fusion between the hybrid EVs and organelles had occurred in the acidic environment of the organelles. When TR-Dex-loaded liposomes were fused with the PD-1 EVs, confocal laser scanning microscopy indicated that TR-Dex was distributed throughout the cells, which suggested that endosomal escape of TR-Dex, through membrane fusion between the hybrid EVs and acidic organelles, had occurred. These engineered PD-1 hybrid EVs have potential as delivery carriers for biopharmaceuticals.

Novel plant-derived exosome-like nanovesicles from Catharanthus roseus: preparation, characterization, and immunostimulatory effect via TNF-α/NF-κB/PU.1 axis

“…1 Hf). As an acidic organelle, the change of pH environment can affect the membrane exchange and membrane fusion of MVB [ 36 , 37 ]. Interestingly, we also observed the vesicle fusion of CLDENs in an acidic environment (Fig.…”

Extracellular Vesicles-Based Cell-Cell Communication in Melanoma: New Perspectives in Diagnostics and Therapy

“…EVs can be modified to obtain better properties e.g., to increase their circulation time by modification with nanobody-PEG-lipids [ 161 ] or decorating them with ligands to apply “eat me/don’t eat me strategy” for drug delivery [ 162 ]. Fusion EVs with cargo-loaded liposomes allows the generation of hybrid EVs that benefit from both the biocompatibility of EVs and the easiness of loading [ 163 ]. The method of directly targeting the recipient cells is one of the most critical factors determining the application of EVs as a carrier of biomolecules.…”

Extracellular Vesicle-Based SARS-CoV-2 Vaccine

“…The composition of lipid membranes can be easily adjusted, and interior and surface modifications are relatively easy. By fusing such liposomes with EVs, it becomes possible to load drugs inside the EVs and modify the lipid composition and surface of the cell membrane [ 159 , 160 ]. One such technique for fusing EVs and liposomes involves using a fusogenic agent, polyethylene glycol (PEG), by which liposomes and EVs fuse through mixing so that more than 60% of membrane and soluble contents are translocated from liposomes to EVs under optimized conditions.…”